Document Detail


Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia.
MedLine Citation:
PMID:  12760977     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IMPLICATIONS: Under conditions of moderate hypovolemia, the maximal acute intravascular volume expansion with the rapid infusion of 1000 mL of lactated Ringer's solution is slightly more than half that achieved with the same volume of 6% Hetastarch.
Authors:
David R McIlroy; Evan D Kharasch
Related Documents :
9787127 - Vasoactivity of adenosine in the trout (oncorhynchus mykiss) coronary system: involveme...
21855227 - An hypothesis on pressure transmission from anterior chamber to optic nerve.
21734087 - Intradialytic hypertension and the association with interdialytic ambulatory blood pres...
21721987 - Association of stroke with ambulatory arterial stiffness index (aasi) in hypertensive p...
1425877 - Increase in cerebrospinal fluid pressure in normocapnic volunteers in response to nalbu...
8449027 - Melatonin does not increase iop significantly in rabbits.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  96     ISSN:  0003-2999     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-05-22     Completed Date:  2003-06-17     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1572-7, table of contents     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology, University of Washington Medical Center, Seattle, USA. d.mcilroy@alfred.org.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Volume / drug effects*
Colloids / therapeutic use*
Cross-Over Studies
Female
Hematocrit
Hetastarch / therapeutic use
Humans
Hypovolemia / physiopathology*,  therapy*
Isotonic Solutions / therapeutic use
Male
Plasma Substitutes / therapeutic use*
Prospective Studies
Grant Support
ID/Acronym/Agency:
M01-RR-00037/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Colloids; 0/Isotonic Solutions; 0/Plasma Substitutes; 0/crystalloid solutions; 8026-10-6/Ringer's solution; 9005-27-0/Hetastarch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Perioperative myocardial ischemia in patients undergoing sternectomy shortly after coronary artery b...
Next Document:  The effect of dexamethasone on side effects after coronary revascularization procedures.